Table 1 The prevalence of hrHPV genotypes in 2897 hrHPV positive women with normal cytology
hrHPV genotypes | Total, n = 4198, (%) | No. of hrHPV positive women with normal cytology n = 2897, (%) | The percentages of women with normal cytology in hrHPV positive women (%) | No. of histological HSIL+, n = 204, (%) | No. of histological high-grade squamous intraepithelial lesion, n = 173, (%) | No. of histological adenocarcinoma in situ and adenocarcinoma, n = 7, (%) | No. of histological squamous cervical cancer, n = 24, (%) |
|---|---|---|---|---|---|---|---|
16 | 1373(32.7) | 874(30.2) | 63.7 | 119(58.3) | 99(57.2) | 2(28.6) | 18(75.0) |
18 | 301(7.2) | 224(7.7) | 74.4 | 12(5.9) | 6(3.5) | 5(71.4) | 1(4.2) |
31 | 221(5.3) | 154(5.3) | 69.7 | 15(7.4) | 13(7.5) | 0 | 2(8.3) |
33 | 360(8.6) | 208(7.2) | 57.8 | 22(10.8) | 21(12.1) | 1(14.3) | 0 |
35 | 41(1.0) | 22(0.8) | 53.7 | 0 | 0 | 0 | 0 |
39 | 234(5.6) | 169(5.8) | 72.2 | 5(2.5) | 5(2.9) | 0 | 0 |
45 | 62(1.5) | 47(1.6) | 75.8 | 2(0.1) | 2(1.1) | 0 | 0 |
51 | 143(3.4) | 101(3.5) | 70.6 | 4(2.0) | 3(1.7) | 0 | 1(4.2) |
52 | 571(13.6) | 395(13.6) | 69.2 | 28(13.7) | 28(16.2) | 0 | 0(0) |
53 | 504(12.0) | 380(13.1) | 75.4 | 10(4.9) | 9(5.2) | 0 | 1(4.2) |
56 | 75(1.8) | 37(1.3) | 49.3 | 0 | 0 | 0 | 0 |
58 | 680(16.2) | 452(15.6) | 66.5 | 26(12.7) | 25(14.5) | 0 | 1(4.2) |
59 | 93(2.2) | 71(2.5) | 76.3 | 1(0.05) | 0 | 0 | 1(4.2) |
66 | 209(5.0) | 143(4.9) | 68.4 | 7(3.4) | 7(4.0) | 0 | 0 |
68 | 166(4.0) | 115(4.0) | 69.3 | 4(2.0) | 4(2.3) | 0 | 0 |